Diamond Hill Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-547
| Closed | -$134K | – | 165 |
|
|
2019
Q4 | $134K | Sell |
547
-2,504
| -82% | -$613K | ﹤0.01% | 157 |
|
|
2019
Q3 | $1.05M | Sell |
3,051
-1,027
| -25% | -$354K | 0.01% | 139 |
|
|
2019
Q2 | $3.75M | Buy |
4,078
+1,785
| +78% | +$1.64M | 0.02% | 136 |
|
|
2019
Q1 | $3.66M | Buy |
2,293
+2,032
| +779% | +$3.24M | 0.02% | 134 |
|
|
2018
Q4 | $487K | Buy |
261
+94
| +56% | +$175K | ﹤0.01% | 157 |
|
|
2018
Q3 | $393K | Buy |
167
+52
| +45% | +$122K | ﹤0.01% | 156 |
|
|
2018
Q2 | $395K | Hold |
115
| – | – | ﹤0.01% | 161 |
|
|
2018
Q1 | $326K | Sell |
115
-41
| -26% | -$116K | ﹤0.01% | 160 |
|
|
2017
Q4 | $401K | Buy |
+156
| New | +$401K | ﹤0.01% | 160 |
|